Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 2 Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Wilms Tumor 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Radiation Injuries 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Low Anterior Resection Syndrome 1 Liposarcoma 1 Leiomyosarcoma 1 Hepatic Veno-Occlusive Disease 1 Glioblastoma 1 Germinoma 1 Fatigue 1 Eyelid Squamous Cell Carcinoma 1

Interventions

Radiosurgery 11 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Nivolumab 4 Mental Status and Dementia Tests 4 Receptors, Interleukin-8B 3 Memantine 3 Ipilimumab 3 trastuzumab deruxtecan 2 pembrolizumab 2 Surveys and Questionnaires 2 sotorasib 1 sapanisertib 1 sacituzumab govitecan 1 pertuzumab 1 patritumab deruxtecan 1 nabiximols 1 fluciclovine F-18 1 entrectinib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 brodalumab 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Vorinostat 1 Vitamin B 6 1 Valacyclovir 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × Surgical Procedures, Operative × 30 days × Clear all

NCT07197632 2026-05-05

MET-MRI

Technical University of Munich

Phase NA Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡